Pola-R-CHP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of randomized trials and real-world evidence. [PDF]
Perrone S +4 more
europepmc +1 more source
Efficacy and safety of subcutaneous mosunetuzumab plus polatuzumab vedotin in patients with relapsed/refractory large B-cell lymphoma: Japan subgroup analysis of the phase III SUNMO trial. [PDF]
Maruyama D +9 more
europepmc +1 more source
Physiologically relevant media are associated with overlapping metabolic responses in primary human hepatocytes and Huh7 cells. [PDF]
Cross E +6 more
europepmc +1 more source
Network meta-analysis of first-line R-CHOP-based regimens in MYC/BCL2 double-expressor diffuse large B-cell lymphoma. [PDF]
Cheng H +8 more
europepmc +1 more source
Low lymphoma macrophage infiltration predicts poor outcomes for R-CHOP- but not Pola-R-CHP-treated patients with DLBCL. [PDF]
Morschhauser F +21 more
europepmc +1 more source
Validation of the thermal stability of EMAIS-SR autonomous packaging for preservation of porcine lungs: cooling curve in an experimental model. [PDF]
Reis FPD +8 more
europepmc +1 more source
Case Report: Frontline CD19 CAR-T-cell therapy combined with targeted regimens induces durable complete remission in newly diagnosed secondary CNS lymphoma: a report of two cases. [PDF]
Pan Q +8 more
europepmc +1 more source
Population genetic evidence of heterogeneous zoonotic transmission of Schistosoma japonicum in endemic communities in the Philippines. [PDF]
Kunluang S +12 more
europepmc +1 more source

